baber/WOPTO huggingface dataset:
Patent EP-1469752-A2 (EP)
Inventor: GOLD DANNY
IPC: A41D19/02
Filed: 2003-02-03
Abstract: La présente invention concerne une construction de gant à coupe américaine dans laquelle on obtient une pré-courbure en des emplacements choisis des doigts, de préférence autour des articulations, en cousant des parties triangulaires de matériau sur des parties coupées de la partie à coupe américaine de façon que les doigts raccourcis et les parties du dos plus grandes se rejoignent facilement et peuvent être réunies sans qu'il soit nécessaire de rassembler ou de coudre à piqûre mocassin le matériau, ce qui permet d'obtenir une forme de doigt telle qu'elle se recourbe en avant vers la partie paume.  On obtient un volume augmenté au bout des doigts de la construction de gant à coupe américaine de l'invention en pinçant les pièces du côté paume des doigts à proximité du bout des doigts.  En outre, pour réduire la rigidité des gants lorsqu'ils se referment sous la forme d'un poing, on enlève une pièce elliptique de la partie paume du gant et on coud ensemble les côtés de la pièce elliptique, formant de la sorte une couture.  La couture est percée de fenêtres donnant sur une pièce de protection fixée sur la partie paume du gant, laquelle pièce de protection est découpée dans une zone située directement au-dessus et autour de la couture et de préférence dans la zone où la main de l'utilisateur se plie normalement lorsque les doigts et la main se referment vers l'intérieur sous la forme d'un poing.  La couture à fenêtres augmente la souplesse du gant.  En outre, en augmentant la longueur de la partie paume des doigts de manière que la partie paume s'enroule autour du bout des doigts et rejoint la partie dos des doigts à une distance du bout des doigts, on réduit de manière significative l'usure de la couture et on augmente la sensibilité au bout des doigts.
Patent EP-1480678-A2 (EP)
Inventor: KARAGEOZIAN VICKEN
IPC: A61P9/00
Filed: 2003-02-13
Abstract: Methods for treating disorders of the eye and/or disorders of a nerve in a human or veterinary patient by delivering to the patient a therapeutically effective amount of a compound selected from the group of; urea, urea derivatives, thiourea, thiourea derivatives, guanidine, guanidine derivatives and compounds having General Formula I as set forth herein. For ophthalmic applications, the compound may be delivered by intravitreal injection such that the compound causes vitreal liquefaction, posteriour vitreoretinal detachment and other affects.
Patent EP-1482854-A2 (EP)
Title: Appareil d'echantillonnage de fluide biologique
Inventor: MATHIAS JEAN-MARIE
IPC: A61B5/155
Filed: 2003-03-13
Abstract: L'invention concerne un appareil d'échantillonnage comprenant un récipient à échantillons comportant a moins une paroi définissant une chambre intérieure de réception de fluide et dotée d'une entrée de fluide conçue pour recevoir le fluide et l'amener dans la chambre, et un récepteur de dispositif d'échantillonnage porté par la paroi du récipient et en communication fluidique avec la chambre, récepteur conçu pour recevoir un dispositif d'échantillonnage conçu pour prélever un échantillon de fluide dans la chambre.
Patent EP-1513977-A2 (EP)
Title: Method for the treatment of covering materials for interior fitting pieces in particular for vehicle interiors and interior fitting pieces
Inventor: WURM HENRY
IPC: D06C3/00
Filed: 2003-05-30
Abstract: A method for the treatment of covering materials for use with a vehicle component, in particular for pieces of trim or vehicle seats, whereby the moisture content of the covering material is temporarily increased, such that the covering material is softened in a treatment chamber by the introduction of moisture and then smoothed by the action of a drawing force extending the covering material is disclosed. A vehicle component treated by the above method, in particular seats, roof linings, and trim pieces for motor vehicles is further disclosed.
Patent EP-1520255-A2 (EP)
Inventor: BRADY JOHN MICHAEL
IPC: G06V10/30
Filed: 2003-06-20
Abstract: Image processing method, particularly suitable for processing noisy images such as digitised mammograms. An adaptive anisotropic diffusion processing method is described in which the diffusion parameter is adjusted in accordance with the contrast in the image. An adaptive foveal segmentation method is also described in which the segmentation parameters are set adaptively in accordance with the contrast in the image.
Patent EP-1559144-A2 (EP)
Inventor: WRISTERS DERICK
IPC: H01L21/336
Filed: 2003-10-27
Abstract: L'invention porte sur un semi-conducteur (100) à effet de champ à grille isolée présentant une région halo sur le côté de la source (120), et sur son procédé de fabrication comporte les étapes suivantes: formation d'une grille sur un substrat (102) semi-conducteur; formation de la région halo sur le côté de la source (120); formation d'espaceurs (127, 128, 152, 154) jouxtant les côtés opposés de la grille; formation d'une région d'extension de source (136A) et d'une région d'extension de drain (138A) dans le substrat (102) au moyen d'un implant incliné, la région d'extension de source (136A) s'étendant sous la grille (112) et la région d'extension de drain (138A) pouvant s'étendre sous la grille (112) ou en être séparée latéralement; et formation d'une région source (156) et d'une région drain (158) dans le substrat (102).
Patent EP-1567089-A2 (EP)
Inventor: WILLIAMS MICHAEL S
IPC: A61F2/06
Filed: 2003-11-12
Abstract: Improved polymeric endoprostheses and methods of making endoprostheses are disclosed. Said endoprostheses exhibit improved overall compliance, selective regional compliance, and selective radial strength without varying the geometries of selected regions. Numerous other physical characteristics of said endoprostheses may be selectively varied during manufacture. Some embodiments may comprise one or more erodible material. Some embodiments may comprise one or more therapeutics incorporated into said endoprosthesis via a solvent in a supercritical state.
Patent EP-1527126-A2 (EP)
Inventor: CHENG PAUL P
IPC: F42B12/74
Filed: 2003-08-07
Abstract: L'invention concerne une composition polymère à haute densité fabriquée à partir de compositions comprenant (a) un liant polymère renfermant des compositions et des mélanges de polyamide et basée sur des monomères contenant de l'hexaméthylènediamine et/ou du coprolactame, et de la résine novolaque phénolique, et (b) une poudre d'alliage métallique ou du métal. L'invention concerne également des articles fabriqués à partir de cette composition. Parmi les articles préférés de cette invention, on peut citer les balles ainsi que d'autres formes de munition. L'invention concerne enfin des procédés de préparation de ces compositions.
Patent EP-1552019-A2 (EP)
Inventor: DOXSEY STEPHEN J
IPC: G01N1/30
Filed: 2003-08-11
Abstract: L'invention repose sur la découverte selon laquelle l'apparition d'anomalies des centrosomes et la survenance d'un cancer sont en corrélation, et selon laquelle plus le degré d'anomalies des centrosomes est élevé, plus la probabilité d'apparition et la gravité du cancer sont importantes. L'invention concerne des méthodes de détection d'anomalies des centrosomes dans des échantillons tissulaires. L'invention propose des nouvelles méthodes prédictives et diagnostiques du cancer.
Patent EP-1540714-A2 (EP)
Inventor: MIKHAEL MICHAEL G
IPC: C23C16/505
Filed: 2003-08-22
Abstract: A plasma is produced in a treatment space (58) by diffusing a plasma gas at atmospheric pressure and subjecting it to an electric field created by two metallic electrodes (54, 56) separated by a dielectric material, a vapor precursor is mixed (52) with the plasma, and a substrate material (14) is coated by vapor deposition of the vaporized substance at atmospheric pressure in the plasma field. The use of vaporized silicon-based materials, fluorine-based materials, chlorine-based materials, and organo-metallic complex materials enables the manufacture of coated substrates with improved properties with regard to moisture-barrier, oxygen-barrier, hardness, scratch- and abrasion-resistance, chemical-resistance, low-friction, hydrophobic and/or oleophobic, hydrophilic, biocide and/or antibacterial, and electrostatic-dissipative/conductive characteristics.
Patent EP-1537020-A2 (EP)
Inventor: PY DANIEL
IPC: A61J1/05
Filed: 2003-09-03
Abstract: A medicament vial assembly includes a storage vial (310), a stopper member (330) and a securing ring (350, 370). The storage vial has a body portion (312) which defines an interior chamber (318) for storing a predetermined medicament and a neck portion through which medicament is received into and withdrawn from the interior chamber. The stopper member (330) is inserted into the mouth of the vial and establishes a first seal. The securing ring (350, 370) is engaged with the mouth of the vial and adapted and configured for retaining the stopper member (330) within the vial mouth and effectuating a second seal.
Patent EP-1567571-A2 (EP)
Inventor: STUDER PEGGY
IPC: G02F1/1337
Filed: 2003-12-02
Abstract: Copolymers composed of (a) at least one monomer from the group of acrylates, methacrylates, acrylamides and methacrylamides, to each of which is bonded covalently, directly or via a bridging group, a photochemically isomerizable or dimerizable molecule, (b) at least one polyoxyalkyl ester or one polyoxyalkylamide of an ethylenically unsaturated mono- or dicarboxylic acid, or one polyoxyalkyl ether of an ethylenically unsaturated alcohol, and (c) optionally, other ethylenically unsaturated comonomers are outstandingly suitable as alignment layers for liquid crystals.
Patent EP-1573314-A2 (EP)
Inventor: CHAN ANDREW CHEE-YUEN
IPC: C12N5/06
Filed: 2003-12-11
Abstract: La présente invention concerne généralement des animaux transgéniques non humains exprimant des marqueurs cellulaires humains, dont CD20. Elle concerne également des méthodes d'utilisation desdits animaux pour identifier des agents pouvant appauvrir efficacement des cellules porteuses du CD20 humain. Les animaux transgéniques de l'invention peuvent également être utilisés pour tester la sécurité et l'efficacité de traitement anti-CD20.
Patent EP-1460568-A2 (EP)
Inventor: YOKOHATA HIDEAKI
IPC: G06F19/00
Filed: 2004-01-26
Abstract: In a computer system for analyzing the flow of an intake/exhaust gas of, for example, a four-cycle multi-cylinder engine through application of CFD, the dimension of a space where the flow of the intake/exhaust gas is analyzed can be selected with respect to each of four processes, that is, intake, compression, expansion and exhaust processes, of each cylinder (in selecting step S1), and a physical model for simulating the flow of the intake/exhaust gas from a part of an intake system to a part of an exhaust system of the engine in the dimension selected with respect to each of the four processes is set (in model setting steps S2, S31, S41 and S51). The flow of the intake/exhaust gas is subjected to a CFD operation using the physical model, and chemical reactions caused in combustion is simulated (in operating steps S33, S43 and S53), so as to output an output about engine performance on the basis of the results of these simulation operations. Thus, while keeping sufficiently high accuracy in the analysis, time required for the CFD operation can be reduced as much as possible, resulting in improving the utility as a design/development tool.
Patent EP-1443695-A2 (EP)
Inventor: MIYATA HIDEYUKI
IPC: H04J14/00
Filed: 2004-01-27
Abstract: A double-ring optical wavelength multiplex
network is disclosed, which includes multiple
optical transmission apparatuses that can reduce the
unit cost of initially installing a small optical
network while providing the flexibility to expand.
For multiplexed optical signals arriving at a node,
the optical transmission apparatus "drops" selected
wavelengths for local delivery and "passes" others
for continued transmission on the network. For
optical signals originating ("added") at the node,
the optical transmission apparatus wavelength
multiplexes the "added" signals with the "passing"
signals for transmission on the network. For "added"
signals, the optical transmission apparatus blocks
"passing" signals of the same wavelength.
Patent EP-1453105-A2 (EP)
Inventor: NISHIWAKI KATSUHIKO
IPC: H01L21/331
Filed: 2004-02-20
Abstract: It is intended to provide a high withstand voltage vertical
field effect type semiconductor device that relaxes electric
fields in a semiconductor substrate without thickening
thickness of a drift region and achieves withstand-ability
against high voltage without sacrificing ON-voltage,
switch-OFF characteristics, and miniaturization. A field
effect type semiconductor device comprises emitter
regions (100,104) and gate electrodes (106) and the like on
a surface (upper surface in FIG.2), a collector region (101)
and the like on the other surface (lower surface in FIG.2),
wherein N - -type field dispersion regions (111) of low impurity
concentration are arranged between P-type body regions (103) facing
to gate electrodes (106) and an N-type drift region (102) below P-type
body regions (103). Thereby, the electric field between
collector and emitter is relaxed and a high withstand voltage
field effect type semiconductor device is realized.
Another field dispersion region can be arranged between the
N-type drift region (102) and P + -type collector region (101) below the
N-type drift region (102).
Patent EP-1517583-A2 (EP)
Inventor: NIEDERDRAENK TORSTEN DR
IPC: H04R25/00
Filed: 2004-09-09
Abstract: The hearing aid has a signal processing device for converting an input signal into an output signal supplied to a transducer converting it into a corresponding sound signal, the electrical input impedance of the transducer used as a measure for an acoustic impedance parameter, with determination of a mechanical resonance from the electrical input impedance characteristic, the shifting of the mechanical resonance from the normal mechanical resonance used for automatic correction of the hearing aid frequency characteristic. An independent claim is included for a method of matching a hearing aid to the acoustic impedance characteristics of the auditory channel of the user .
Patent EP-1508948-A2 (EP)
Inventor: RICHIE WILLIAM S JR
IPC: H01T23/00
Filed: 1999-08-16
Abstract: A room ionization system includes a plurality of
emitter modules, each including an electrical ionizer. The
emitter modules are spaced around the room and are connected
in a daisy-chain manner to a system controller. Each
emitter module has an individual address for allowing the
system controller or a remote control transmitter to
individually address and control each emitter module.
Electrical lines containing both power and communication
lines connect the plurality of emitter modules with the
system controller. Each emitter module stores a balance
reference value and an ion output current reference value
for use by automatic balance control and automatic ion
output current control circuitry. These reference values
are stored in a software-adjustable memory so that they may
be easily changed via the system controller or via the
remote control transmitter if actual measured balance or
decay times in the work space, such as measured by a charged
plate monitor, indicate an ion imbalance or out of range ion
output current. Each emitter module can send detailed alarm
condition information and emitter module identification
information to the system controller upon detection of a
malfunction. Each emitter module connected to the system
controller may be individually set to a desired operating
power mode. The emitter modules use a switching power
supply to lessen effects of line loss. Each emitter module
includes miswire protection circuitry so that the electrical
lines may be automatically flipped if initially connected in
the reverse manner.
Patent EP-1547962-A2 (EP)
Inventor: KOMIZO KENICHIRO
IPC: B66C1/36
Filed: 2004-12-22
Abstract: A hook (1) comprises a pair of hook bodies (2, 2), a pair
of hook portion (3, 3), a movable pressing portion (5), an
operating portion (7) and a link unit (8). The hook bodies
(2, 2) are formed of two plates disposed apart from each other,
respectively. The hook portions (3, 3) are integrally fixed
to lower ends of the hook bodies (2, 2), respectively. The
movable pressing portion (5) is rotatably supported between
the hook portions (3, 3). The operating portion (7) is subject
to a tension load of a hoist. The link unit (8) has both ends
rotatalby connected to the movable pressing portion (5) and
the operating portion (7). If the operating portion (7) is
pulled upward, the movable pressing portion (5) presses a wire
harness (WH), which is hooked to the hook portion (3), against
the hook portion (3).
Patent EP-1534052-A2 (EP)
Inventor: CHENGALVA SURESH K
IPC: H05K3/00
Filed: 2004-11-18
Abstract: A circuit board assembly (10) comprising a laminate substrate (12)
and a surface mount device (18) having a CTE less than that of the laminate
substrate (12) and attached with at least one solder joint (20) to a first surface
(14) of the laminate substrate (12). The assembly (10) further includes a
localized stiffener (24,124,224) attached to a second surface (16) of the
laminate substrate (12) so as to be directly opposite the circuit device (18).
The localized stiffener (24,124,224) is formed of a material and is shaped so
that, when attached to the laminate substrate (12), the stiffener (24,124,224) is
capable of increasing the thermal cycle fatigue life of the one or more solder
joints (20) that attach the device (18) to the substrate (12).
Patent EP-1537919-A2 (EP)
Inventor: KOERNIG MATTHIAS
IPC: E01C23/00
Filed: 2004-11-17
Abstract: The decontamination process is used in the event of pollution by polycyclic aromatic carbohydrates and/or phenols. It involves using a mixed culture of microorganisms containing at least the following five forms: DSM 8219 (Pseudomonas perfetomarina, stutzeri); DSM 20109 (Cellulommionas flavigena); DSB 291 (Pseudomonas putida); DSM 6506 (Pseudomonas fluorescens); DSM 6612 (Arthrobacter oxydans); and DSM 4762 (Acidovorac delafieldii). Material thus treated can be re-used as a binder.
Patent EP-1477792-A2 (EP)
Inventor: CHEN XIAOXI
IPC: B01L3/00
Filed: 2004-05-13
Abstract: The subject invention provides a sample processing technique for purifying a
biological or chemical sample. The invention is particularly well-suited to prepare a
sample for mass spectrometry. The process is to be performed in an article having at least
one well, in which the surface of the well is at least partially hydrophobic and/or modified
with bio-specific ligands. Targeted solutes, such as salts or small molecule contaminants,
can be removed from a solution to allow for a purified solution of a desired type of solute,
such as peptides and/or proteins.
Patent EP-1553789-A2 (EP)
Inventor: MATTILA PEKKA
IPC: H04B7/04
Filed: 2004-12-17
Abstract: By means of the present solution, a wireless data transmission is enabled between
a ship (L) sailing at sea and an on-land telecommunications network
(N). The solution involves utilizing a microwave radio link between the ship and
an on-land base station (BS1, BS2, BS3, BS4). The network (N) maintains information
of the ship route (R) such that the base station (BS1, BS2, BS3,
BS4) knows when a ship (L) is approaching its area (CA1, CA2, CA3, CA4).
Accordingly, the ship (L) knows which base station (BS1, BS2, BS3, BS4) it is
approaching. The accurate transmission direction is determined by means of a
gyroscope and the GPS location of the ship (L).
Patent EP-1508834-A2 (EP)
Title: Nanoparticle-filled stereolithographic resins
Inventor: STEINMANN BETTINA
IPC: G03F7/038
Filed: 2004-07-02
Abstract: A liquid radiation-curable composition useful for the production of three
dimensional articles by stereolithography that comprises:
   (a) at least one free-radical polymerizing organic substance;   (b) at least one free-radical polymerization initiator;   (d) at least one filler comprising silica-type nanoparticles
suspended in the radiation-curable composition;   (d) at least one cationically polymerizing organic substance;   (e) at least one cationic polymerization initiator;   (f) optionally, at least one hydroxyl-functional compound; and   (g) optionally, at least one type of microparticle filler.
Patent EP-1557757-A2 (EP)
Inventor: FRESKO NEDIM
IPC: G06F9/44
Filed: 2004-12-21
Abstract: A system and method for inducing asynchronous behavioral changes in a
managed application process are provided. An application manager process is
executed. A managed application process is executed. At least one application
provided as object-oriented program code under the control of a managed code
platform is executed. The managed application process logically communicates
with the application manager process. One or more constructors corresponding to
notifiable objects provided as object-oriented program code are identified. Each
constructor keeps track of instantiated notifiable objects in a list in the managed
application process. A change request is broadcast to the managed application
process. The notifiable objects tracked by each identified constructor are iterated
over to effect a behavioral change in the managed application process.
Patent EP-1593079-A2 (EP)
Inventor: MARTUCCI JAMES P
IPC: G06F19/00
Filed: 2004-01-30
Abstract: La présente invention a trait à un système et un procédé permettant l'exécution d'une comparaison d'un paramètre de fonctionnement d'un dispositif médical avec une commande.
Patent EP-1596799-A2 (EP)
Inventor: DAUM WOLFGANG
IPC: A61N2/00
Filed: 2004-02-06
Abstract: L'invention porte sur des méthodes de traitement de cellules, de tissu malade, d'agents pathogènes ou d'autres matières indésirables, ces méthodes consistant à administrer une biosonde (matériaux sensibles à l'énergie qui sont fixés à un ligand spécifique d'une cible) dans le corps d'un patient, dans une partie du corps, dans un tissu ou dans un fluide biologique (tel que le sang, le plasma sanguin ou le sérum sanguin). Une source d'énergie envoie l'énergie à la biosonde de façon à détruire, rompre ou inactiver la cible. Diverses formes d'énergie telles que le champ magnétique alternatif, l'hyperfréquence, l'énergie acoustique ou une combinaison de celles-ci peuvent être utiles dans le traitement de différents états tels que notamment, mais pas exclusivement, tous types de cancer tels que le cancer de la moelle osseuse, du poumon, du système vasculaire, du système nerveux central, du côlon, des ovaires, du sein et de la prostate, le SIDA, l'angiogenèse tumorale, la resténose, l'amyloïdose, la tuberculose, l'obésité, la malaria et les maladies dues à des virus tels que le VIH.
Patent EP-1606669-A2 (EP)
Inventor: CAVANAUGH SHANTI A
IPC: G02F1/1339
Filed: 2004-02-21
Abstract: L'invention concerne un atténuateur [100] optique variable de cristaux liquides nématiques torsadés, qui comporte un substrat comprenant un polariseur [111] nanostructuré à sous-longueur d'onde intégré. Le dispositif peut comprendre un isolant intégré, dans lequel un substrat du sandwich de cristaux liquides est formé à partir de grenat dopé et comporte un rotateur Faraday, lequel est gravé de manière à former un réseau de polarisation nanostructuré optique à sous-longueur d'onde, ce qui permet au substrat de servir d'isolant. L'atténuateur optique peut comprendre une barrière [106] contre l'humidité équipée d'un joint d'étanchéité métallique déposé qui lie les substrats supérieur et inférieur opposés, chacun de ceux-ci comprenant une couche d'espacement [107] permettant de régler précisément l'épaisseur de l'espace intracellulaire. Cet atténuateur [100] peut aussi comprendre une couche [108] déposée intégrée de détection thermique et de chauffe, prise en sandwich entre les substrats opposés ou déposée sur l'un et/ou l'autre de ceux-ci.